Difference in outcome among women and men after percutaneous mitral valvuloplasty

Catheterization and Cardiovascular Interventions

Volumn 77, Issue 1, 2011, Pages 115-120

  Cruz Gonzalez, Ignacio ^a,b   Jneid, Hani ^a   Sanchez Ledesma, Maria ^a,b   Cubeddu, Roberto J ^a   Martin Moreiras, Javier ^b   Rengifo Moreno, Pablo ^a   Diaz, Tullio A ^c   Kiernan, Thomas J ^a   Inglessis Azuaje, Ignacio ^a   Maree, Andrew O ^a   Sanchez, Pedro L ^d   Palacios, Igor F ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^c ST ELIZABETH'S MEDICAL CENTER   (United States)

^d HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

mitral stenosis; mitral valvuloplasty; VALV; valvular heart disease

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; MITRAL VALVE STENOSIS; PERCUTANEOUS MITRAL VALVULOPLASTY; SEX DIFFERENCE; TREATMENT OUTCOME;

ADULT; AGED; BALLOON DILATION; CHI-SQUARE DISTRIBUTION; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE STENOSIS; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; SPAIN; TIME FACTORS; TREATMENT OUTCOME;

EID: 78650642579     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22721     Document Type: Article

References (16)

1. Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, et al. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007; 28: 230-268.
2. Bonow RO, Carabello BA, Chatterjee K, de Leon AC, Jr., Faxon DP, Freed MD, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 2006; 48: e1-e148.
3. Palacios IF, Sanchez PL, Harrell LC, Weyman AE, Block PC,. Which patients benefit from percutaneous mitral balloon valvuloplasty? Prevalvuloplasty and postvalvuloplasty variables that predict long-term outcome. Circulation 2002; 105: 1465-1471.
4. Vahanian A, Palacios IF,. Percutaneous approaches to valvular disease. Circulation 2004; 109: 1572-1579.
5. Prendergast BD, Shaw TR, Iung B, Vahanian A, Northridge DB,. Contemporary criteria for the selection of patients for percutaneous balloon mitral valvuloplasty. Heart 2002; 87: 401-404.
6. Yetkin E, Qehreli S, Ileri M, Senen K, Enen Atak R, Yanik A, Yetkin O, Sasmaz H,. Comparison of clinical echocardiographic and hemodynamic characteristics of male and female patients who underwent mitral balloon valvuloplasty. Angiology 2001; 52: 835-839.
7. Hernandez RA, Banuelos C, Alfonso F, Goicolea J, Segovia J, Castillo JA, Zarco P, Macaya C,. Differences in initial and long-term results of percutaneous mitral valvulotomy as a function of sex. Rev Esp Cardiol 1994; 47 (Suppl 3): 60-67.
8. Iung B, Cormier B, Ducimetiere P, Porte JM, Nallet O, Michel PL, Acar J, Vahanian A,. Immediate results of percutaneous mitral commissurotomy. A predictive model on a series of 1514 patients. Circulation 1996; 94: 2124-2130. (Pubitemid 26360504)
9. Palacios I, Block PC, Brandi S, Blanco P, Casal H, Pulido JI, Munoz S, D'Empaire G, Ortega MA, Jacobs M,. Percutaneous balloon valvotomy for patients with severe mitral stenosis. Circulation 1987; 75: 778-784.
10. Gorlin R, Gorlin SG,. Hydraulic formula for calculation of the area of the stenotic mitral valve, other cardiac valves, and central circulatory shunts. Am Heart J 1951; 41: 1-29.
11. Tuzcu EM, Block PC, Griffin B, Dinsmore R, Newell JB, Palacios IF,. Percutaneous mitral balloon valvotomy in patients with calcific mitral stenosis: Immediate and long-term outcome. J Am Coll Cardiol 1994; 23: 1604-1609.
12. Wilkins GT, Weyman AE, Abascal VM, Block PC, Palacios IF,. Percutaneous balloon dilatation of the mitral valve: An analysis of echocardiographic variables related to outcome and the mechanism of dilatation. Br Heart J 1988; 60: 299-308.
13. Sutaria N, Northridge DB, Shaw TR,. Significance of commissural calcification on outcome of mitral balloon valvotomy. Heart 2000; 84: 398-402.
14. Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Barwolf C, Levang OW, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003; 24: 1231-1243.
15. Avierinos JF, Inamo J, Grigioni F, Gersh B, Shub C, Enriquez-Sarano M,. Sex differences in morphology and outcomes of mitral valve prolapse. Ann Intern Med 2008; 149: 787-795.
16. Coats AJ,. Ethical authorship and publishing. Int J Cardiol 2009; 131: 149-150.